Sanofi Gets Reprieve In Amphastar's Lovenox FCA Suit
A California federal judge on Friday dismissed a False Claims Act suit accusing Sanofi-Aventis SA of making false patent claims for anti-clotting drug Lovenox to unfairly keep generic competition off the...To view the full article, register now.
Already a subscriber? Click here to view full article